SMS Pharmaceuticals Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹206.96 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 13.02 per cent from ₹237.95 crore. This corresponds to a year-on-year *(YoY) growth of 5.56 per cent.
Operating Profit
Operating Profit stands at ₹40.95 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.63 per cent from ₹39.90 crore. This corresponds to a year-on-year *(YoY) growth of 4.01 per cent.
PBDT
PBDT stands at ₹37.90 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 22.56 per cent from ₹48.94 crore. This corresponds to a year-on-year *(YoY) growth of 5.60 per cent.
Profit Before Tax
Profit Before Tax stands at ₹27.91 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 28.09 per cent from ₹38.81 crore. This corresponds to a year-on-year *(YoY) growth of 6.77 per cent.
Net Profit
Net Profit stands at ₹20.91 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 36.07 per cent from ₹32.71 crore. This represents a 2.05 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
SMS Pharmaceuticals Ltd Earnings
- YOY
- QOQ
SMS Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
SMS Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
SMS Pharmaceuticals Ltd Financial Reports
SMS Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| SMS Pharma. | 2.14% | 8.13% | 10.09% | 44.07% | 30.65% | 81.91% |
| Orchid Pharma | 3.59% | -1.55% | -9.17% | -11.32% | 40.35% | 4.54% |
| Senores Pharma. | 0.46% | -6.43% | -13.80% | -13.80% | 29.33% | 38.66% |
| Guj. Themis Bio. | 2.42% | 3.69% | 4.21% | 8.91% | 1.57% | -13.67% |
| Gufic BioScience | 4.49% | 2.43% | 2.39% | 9.39% | 49.98% | 28.61% |
| RPG LifeScience. | 3.02% | -13.11% | -10.00% | -3.96% | 12.18% | 8.67% |
| Novartis India | 1.13% | -4.08% | -11.56% | 6.52% | 67.55% | 109.20% |
Company Info
Company Information
Chairman / Executive Director / Managing Director : P Ramesh Babu
Independent Non Exe. Director : Sarvepalli Srinivas
Independent Non Exe. Director : Shravan Kudaravalli
Independent Non Exe. Director : G Suresh Kumar
Independent Non Exe. Director : Shanti Sree Bolleni
Non-Exec & Non-Independent Dir : Trilok Potluri
Non-Exec & Non-Independent Dir : Sunkara Venkata Satya Shiva Prasad
Executive Director : Vamsi Krishna potluri
Company Sec. & Compli. Officer : Thirumalesh Tumma